| scholarly article | Q13442814 |
| P50 | author | Borna Mehrad | Q41554549 |
| P2093 | author name string | Marie D Burdick | |
| Robert M Strieter | |||
| P2860 | cites work | Mechanism of action and in vivo role of platelet-derived growth factor | Q22010594 |
| Oxygen-regulated transcription factors and their role in pulmonary disease | Q24791474 | ||
| Cell signaling by receptor tyrosine kinases | Q27860474 | ||
| Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1 | Q28141355 | ||
| Loss of PTEN facilitates HIF-1-mediated gene expression | Q28145476 | ||
| Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 | Q29615241 | ||
| Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches | Q29617460 | ||
| Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics | Q29617786 | ||
| Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix | Q29619797 | ||
| Modulation of the Protein Kinase Activity of mTOR | Q30311975 | ||
| Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease | Q30442380 | ||
| Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia | Q33279493 | ||
| CXCR4: chemokine receptor extraordinaire | Q34118771 | ||
| Morphometric analysis of insulin-like growth factor-I localization in lung tissues of patients with idiopathic pulmonary fibrosis | Q77563810 | ||
| Dual-immunohistochemistry provides little evidence for epithelial-mesenchymal transition in pulmonary fibrosis | Q80597495 | ||
| Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis | Q80977273 | ||
| Gefitinib prevents bleomycin-induced lung fibrosis in mice | Q83896403 | ||
| mTOR inhibitors in the treatment of cancer | Q94801373 | ||
| Platelet-derived growth factor in idiopathic pulmonary fibrosis | Q34261287 | ||
| CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury | Q34399563 | ||
| HIV entry inhibitors. | Q34654433 | ||
| Bone marrow-derived progenitor cells in pulmonary fibrosis | Q35022598 | ||
| Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis | Q35080464 | ||
| Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition | Q35083605 | ||
| Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis | Q35131138 | ||
| Insulin-like growth factor-binding protein-5 induces pulmonary fibrosis and triggers mononuclear cellular infiltration | Q35607286 | ||
| Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an alpha-smooth muscle actin-Cre transgenic mouse | Q35608869 | ||
| Circulating fibrocytes: collagen-secreting cells of the peripheral blood | Q35686362 | ||
| Essential roles of the CC chemokine ligand 3-CC chemokine receptor 5 axis in bleomycin-induced pulmonary fibrosis through regulation of macrophage and fibrocyte infiltration. | Q35781428 | ||
| Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P. | Q35787045 | ||
| Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats | Q35787237 | ||
| CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment | Q36306137 | ||
| Regulation of the chemokine receptor CXCR4 by hypoxia | Q36371842 | ||
| Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. | Q36403334 | ||
| Platelet-derived growth factor-dependent activation of phosphatidylinositol 3-kinase is regulated by receptor binding of SH2-domain-containing proteins which influence Ras activity | Q36563209 | ||
| Mobilizing stem cells from normal donors: is it possible to improve upon G-CSF? | Q36763610 | ||
| Cysteinyl leukotrienes are autocrine and paracrine regulators of fibrocyte function | Q36822323 | ||
| Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis | Q36849123 | ||
| The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? | Q36970923 | ||
| Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis | Q37036076 | ||
| Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization | Q37306633 | ||
| Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells | Q38311709 | ||
| Haematologic Adaptation in Patients with Chronic Bronchitis and Pulmonary Insufficiency | Q39085649 | ||
| Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypox | Q40440548 | ||
| Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. | Q40633683 | ||
| OXYGEN SATURATION OF STERNAL MARROW BLOOD IN POLYCYTHEMIA VERA. | Q40999810 | ||
| Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide | Q41197059 | ||
| Mechanisms of fibrosis in coal workers' pneumoconiosis. Increased production of platelet-derived growth factor, insulin-like growth factor type I, and transforming growth factor beta and relationship to disease severity | Q41438692 | ||
| Enhanced insulin-like growth factor molecules in idiopathic pulmonary fibrosis | Q41665426 | ||
| G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow | Q41788910 | ||
| The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. | Q42105688 | ||
| The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases | Q43671920 | ||
| Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis | Q43864575 | ||
| The rapamycin analogue SDZ RAD attenuates bleomycin-induced pulmonary fibrosis in rats. | Q44056582 | ||
| Circulating progenitor epithelial cells traffic via CXCR4/CXCL12 in response to airway injury | Q47653534 | ||
| Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis | Q61892487 | ||
| Peripheral blood fibrocytes: differentiation pathway and migration to wound sites | Q73966720 | ||
| Oxygen saturation in the bone marrow of healthy volunteers | Q77468027 | ||
| P433 | issue | 8-9 | |
| P921 | main subject | pulmonary fibrosis | Q32446 |
| P304 | page(s) | 1708-1718 | |
| P577 | publication date | 2009-03-06 | |
| P1433 | published in | International Journal of Biochemistry & Cell Biology | Q6051320 |
| P1476 | title | Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis | |
| P478 | volume | 41 |
| Q42594342 | "Scar-cinoma": viewing the fibrotic lung mesenchymal cell in the context of cancer biology. |
| Q27335099 | A novel telomerase activator suppresses lung damage in a murine model of idiopathic pulmonary fibrosis |
| Q28660307 | Activated Wnt signaling induces myofibroblast differentiation of mesenchymal stem cells, contributing to pulmonary fibrosis |
| Q35163605 | Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide |
| Q41222578 | Alternative strategies to manipulate fibrocyte involvement in the fibrotic tissue response: pharmacokinetic inhibition and the feasibility of directed-adipogenic differentiation |
| Q49912722 | Anti-fibrotic Effects of CXCR4-Targeting i-body AD-114 in Preclinical Models of Pulmonary Fibrosis. |
| Q30415864 | Bone marrow derived "fibrocytes" contribute to tumor proliferation and fibrosis in gastric cancer |
| Q34887528 | Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer |
| Q34154288 | Caveolin-1 deficiency may predispose African Americans to systemic sclerosis-related interstitial lung disease |
| Q36093857 | Caveolin-1 signaling in lung fibrosis |
| Q38917825 | Chemokine (C-C motif) ligand 2 mediates direct and indirect fibrotic responses in human and murine cultured fibrocytes. |
| Q35138504 | Chemokine receptor Cxcr4 contributes to kidney fibrosis via multiple effectors |
| Q34387011 | Circulating fibrocytes and Crohn's disease. |
| Q30362039 | Circulating fibrocytes as biomarker of prognosis in Hermansky-Pudlak syndrome. |
| Q56480036 | Circulating fibrocytes as biomarkers of impaired lung function in adults with sickle cell disease |
| Q30277093 | Circulating fibrocytes as predictors of adverse events in unstable angina |
| Q30425688 | Circulating fibrocytes correlate with bronchiolitis obliterans syndrome development after lung transplantation: a novel clinical biomarker |
| Q37087273 | Circulating fibrocytes prepare the lung for cancer metastasis by recruiting Ly-6C+ monocytes via CCL2. |
| Q42154997 | Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. |
| Q34517655 | Clinical significance of mTOR, ZEB1, ROCK1 expression in lung tissues of pulmonary fibrosis patients |
| Q28083363 | Contribution of bone marrow-derived fibrocytes to liver fibrosis |
| Q37594222 | Determinants of initiation and progression of idiopathic pulmonary fibrosis |
| Q36589609 | Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis |
| Q37362387 | Differential regulation of cell functions by CSD peptide subdomains |
| Q30419423 | Elevated circulating fibrocyte levels in patients with hypertensive heart disease |
| Q82331355 | Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis |
| Q47141962 | Essential involvement of the CX3CL1-CX3CR1 axis in bleomycin-induced pulmonary fibrosis via regulation of fibrocyte and M2 macrophage migration |
| Q33588795 | FELD better not thinking of metastases only when liver lesions appear after bleomycin-based treatment for non-seminoma testis from metastases |
| Q36232242 | FcγRI mediates serum amyloid P inhibition of fibrocyte differentiation |
| Q33916589 | Fibrocyte measurement in peripheral blood correlates with number of cultured mature fibrocytes in vitro and is a potential biomarker for interstitial lung disease in Rheumatoid Arthritis. |
| Q30426516 | Fibrocytes and the pathogenesis of diffuse parenchymal lung disease |
| Q37887074 | Fibrocytes and the tissue niche in lung repair |
| Q83371739 | Fibrocytes in health and disease |
| Q33759478 | Fibrocytes in the fibrotic lung: altered phenotype detected by flow cytometry |
| Q30432829 | Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis |
| Q36690680 | Fibrocytes: emerging effector cells in chronic inflammation |
| Q39634075 | Fibrocytes: emerging effector cells in chronic inflammation |
| Q38206104 | Fibrosis--a lethal component of systemic sclerosis |
| Q37698325 | Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report |
| Q89995898 | HIV-1 Protein gp120 Induces Mouse Lung Fibroblast-to-Myofibroblast Transdifferentiation via CXCR4 Activation |
| Q30432500 | Human circulating fibrocytes have the capacity to differentiate osteoblasts and chondrocytes |
| Q34820282 | Hypoxia and the extracellular matrix: drivers of tumour metastasis |
| Q36102435 | IL-13 induces skin fibrosis in atopic dermatitis by thymic stromal lymphopoietin. |
| Q36718129 | Implicating exudate macrophages and Ly-6C(high) monocytes in CCR2-dependent lung fibrosis following gene-targeted alveolar injury |
| Q35054706 | Increased CD40+ Fibrocytes in Patients With Idiopathic Orbital Inflammation. |
| Q41439207 | Increased circulating fibrocytes are associated with higher reticulocyte percent in children with sickle cell anemia |
| Q47606025 | Inflammatory protein expression in human subglottic stenosis tissue mirrors that in a murine model |
| Q30414598 | Inhibiting CXCL12 blocks fibrocyte migration and differentiation and attenuates bronchiolitis obliterans in a murine heterotopic tracheal transplant model |
| Q47946445 | Inhibition of Wnt/β-catenin signaling promotes engraftment of mesenchymal stem cells to repair lung injury |
| Q35088560 | Inhibition of angiogenesis, fibrosis and thrombosis by tetramethylpyrazine: mechanisms contributing to the SDF-1/CXCR4 axis |
| Q47990590 | Inhibition of endothelial nitric oxide synthase induces and enhances myocardial fibrosis |
| Q41640757 | Intersection of Chemokine and TSH Receptor Pathways in Human Fibrocytes: Emergence of CXCL-12/CXCR4 Cross Talk Potentially Relevant to Thyroid-Associated Ophthalmopathy |
| Q37562363 | Lysophosphatidic acid accelerates lung fibrosis by inducing differentiation of mesenchymal stem cells into myofibroblasts. |
| Q91121482 | Mesenchymal Regulation of the Microvascular Niche in Chronic Lung Diseases |
| Q47123592 | Mesenchymal stem cells in idiopathic pulmonary fibrosis |
| Q47566394 | Mesenchymal stem cells: A double-edged sword in radiation-induced lung injury |
| Q49603082 | Modeling Idiopathic Pulmonary Fibrosis in Humanized SCID Mice. |
| Q34720147 | New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis |
| Q34903224 | Novel therapeutic approaches for pulmonary fibrosis |
| Q37668864 | Phosphatidylinositol 3-kinase isoforms as targets in respiratory disease. |
| Q54635608 | Phosphoinositide 3-kinase γ plays a critical role in bleomycin-induced pulmonary inflammation and fibrosis in mice. |
| Q37775693 | Potential role for bone marrow-derived fibrocytes in the orbital fibroblast heterogeneity associated with thyroid-associated ophthalmopathy. |
| Q42368982 | R1R2 peptide ameliorates pulmonary fibrosis in mice through fibrocyte migration and differentiation |
| Q35029260 | Rapamycin Regulates Bleomycin-Induced Lung Damage in SP-C-Deficient Mice |
| Q30409683 | Rapamycin blocks fibrocyte migration and attenuates bronchiolitis obliterans in a murine model |
| Q42479992 | Rapamycin increases CCN2 expression of lung fibroblasts via phosphoinositide 3-kinase |
| Q33676236 | Rapamycin protects mice from staphylococcal enterotoxin B-induced toxic shock and blocks cytokine release in vitro and in vivo |
| Q34494156 | Reactive response of fibrocytes to vocal fold mucosal injury in rat |
| Q51720099 | Role of platelet-derived growth factor/platelet-derived growth factor receptor axis in the trafficking of circulating fibrocytes in pulmonary fibrosis. |
| Q42061983 | Role of semaphorin 7a signaling in transforming growth factor β1-induced lung fibrosis and scleroderma-related interstitial lung disease |
| Q44535802 | SDF-1α reduces fibronectin expression in rat mesangial cells induced by TGF-β1 and high glucose through PI3K/Akt pathway |
| Q89312939 | Sca-1+ cardiac fibroblasts promote development of heart failure |
| Q30411470 | Short-course rapamycin treatment preserves airway epithelium and protects against bronchiolitis obliterans |
| Q35813675 | Surfactant protein-D regulates effector cell function and fibrotic lung remodeling in response to bleomycin injury |
| Q95643235 | Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti-PD-L1 immunotherapy |
| Q89909282 | The autocrine CXCR4/CXCL12 axis contributes to lung fibrosis through modulation of lung fibroblast activity |
| Q35723493 | The distribution of immunomodulatory cells in the lungs of patients with idiopathic pulmonary fibrosis |
| Q43515977 | The endothelin A receptor mediates fibrocyte differentiation in chronic obstructive asthma. The involvement of connective tissue growth factor |
| Q28075842 | The extracellular matrix - the under-recognized element in lung disease? |
| Q37415507 | The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis |
| Q30433418 | The role of fibrocytes in fibrotic diseases of the lungs and heart |
| Q30427773 | The role of fibrocytes in sickle cell lung disease |
Search more.